Paul Lohan presents on MSC cell therapy in high risk cornea transplantation

VISICORT researcher Dr Paul Lohan presented his work on MSC cell therapy in high risk cornea transplantation at the Regenerative Medicine Institute (REMEDI) seminar which took place in the Biomedical Sciences Building NUI Galway on Thursday 8th June. The seminar was attended by research scientists and principal investigators.